title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,molecule_ch1,extract_protocol_ch1,extract_protocol_ch1.1,taxid_ch1,description,description.1,data_processing,data_processing.1,data_processing.2,data_processing.3,data_processing.4,data_processing.5,data_processing.6,data_processing.7,platform_id,contact_name,contact_email,contact_department,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,data_row_count,instrument_model,library_selection,library_source,library_strategy,relation,relation.1,relation.2,supplementary_file_1,disease state:ch1,tissue region:ch1,tissue:ch1,condition
C_0034_BA9,GSM3713446,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: control,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0034_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358695,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654043,,NONE,control,BA9 prefrontal cortex,brain,Control
C_0074_BA9,GSM3713447,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: control,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0074_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358693,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654044,,NONE,control,BA9 prefrontal cortex,brain,Control
C_0091_BA9,GSM3713448,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: control,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0091_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358692,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654045,,NONE,control,BA9 prefrontal cortex,brain,Control
C_0113_CAP,GSM3713449,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,CAU,Homo sapiens,disease state: control,tissue: brain,tissue region: CAU,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0113_CAP_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358691,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654046,,NONE,control,CAU,brain,Control
C_0114_CAP,GSM3713450,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,CAU,Homo sapiens,disease state: control,tissue: brain,tissue region: CAU,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0114_CAP_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358690,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653962,,NONE,control,CAU,brain,Control
H_0513_BA9,GSM3713451,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0513_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358689,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653963,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0601_BA9,GSM3713452,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0601_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358694,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653964,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0656_BA9,GSM3713453,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0656_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358688,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653965,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0689_BA9,GSM3713454,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0689_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358687,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653966,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0709_BA9,GSM3713455,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0709_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358682,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653967,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0723_BA9,GSM3713456,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0723_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358681,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653968,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_1104_BA9,GSM3713457,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_1104_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358581,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653969,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_1104_CAP,GSM3713458,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,CAU,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: CAU,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_1104_CAP_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358644,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653970,,NONE,Huntington's Disease,CAU,brain,HD
H_1105_BA9,GSM3713459,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_1105_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358686,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653971,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_1105_CAP,GSM3713460,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,CAU,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: CAU,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_1105_CAP_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358685,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653972,,NONE,Huntington's Disease,CAU,brain,HD
H_1106_BA9,GSM3713461,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_1106_BA9_mRNASeq,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358684,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653973,,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0002 (re-analyzed),GSM3713462,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0002,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580869,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358683,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653974,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0003 (re-analyzed),GSM3713463,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0003,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580870,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358643,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653975,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0004 (re-analyzed),GSM3713464,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0004,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580871,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358642,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653976,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0005 (re-analyzed),GSM3713465,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0005,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580872,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358641,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653977,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0006 (re-analyzed),GSM3713466,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0006,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580873,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358640,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653978,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0008 (re-analyzed),GSM3713467,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0008,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580874,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358639,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653979,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0009 (re-analyzed),GSM3713468,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0009,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580875,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358638,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653980,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0010 (re-analyzed),GSM3713469,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0010,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580876,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358637,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653981,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0011 (re-analyzed),GSM3713470,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0011,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580877,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358636,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653982,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0012 (re-analyzed),GSM3713471,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0012,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580878,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358635,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653983,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0013 (re-analyzed),GSM3713472,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0013,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580879,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358634,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653984,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0014 (re-analyzed),GSM3713473,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0014,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580880,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358633,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653985,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0015 (re-analyzed),GSM3713474,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0015,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580881,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358598,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653986,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0016 (re-analyzed),GSM3713475,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0016,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580882,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358597,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653987,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0017 (re-analyzed),GSM3713476,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0017,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580883,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358596,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653988,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0018 (re-analyzed),GSM3713477,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0018,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580884,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358595,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653989,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0019 (re-analyzed),GSM3713478,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0019,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580885,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358594,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653990,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0020 (re-analyzed),GSM3713479,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0020,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580886,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358593,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653991,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0021 (re-analyzed),GSM3713480,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0021,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580887,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358592,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653992,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0022 (re-analyzed),GSM3713481,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0022,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580888,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358591,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653993,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0023 (re-analyzed),GSM3713482,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0023,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580889,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358590,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653994,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0024 (re-analyzed),GSM3713483,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0024,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580890,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358589,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653995,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0025 (re-analyzed),GSM3713484,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0025,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580891,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358586,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653996,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0026 (re-analyzed),GSM3713485,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0026,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580892,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358585,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653997,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0029 (re-analyzed),GSM3713486,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0029,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580893,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358584,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653998,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0031 (re-analyzed),GSM3713487,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0031,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580894,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358583,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5653999,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0032 (re-analyzed),GSM3713488,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0032,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580895,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358582,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654000,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0033 (re-analyzed),GSM3713489,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0033,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580896,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358588,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654001,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0035 (re-analyzed),GSM3713490,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0035,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580897,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358587,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654002,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0036 (re-analyzed),GSM3713491,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0036,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580898,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358675,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654003,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0037 (re-analyzed),GSM3713492,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0037,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580899,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358674,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654004,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0038 (re-analyzed),GSM3713493,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0038,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580900,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358673,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654005,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0039 (re-analyzed),GSM3713494,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0039,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580901,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358672,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654006,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0050 (re-analyzed),GSM3713495,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0050,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580902,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358671,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654007,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0053 (re-analyzed),GSM3713496,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0053,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580903,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358670,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654008,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0060 (re-analyzed),GSM3713497,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0060,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580904,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358669,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654009,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0061 (re-analyzed),GSM3713498,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0061,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580905,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358668,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654010,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0062 (re-analyzed),GSM3713499,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0062,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580906,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358667,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654011,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0065 (re-analyzed),GSM3713500,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0065,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580907,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358666,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654012,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0069 (re-analyzed),GSM3713501,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0069,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580908,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358665,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654013,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0070 (re-analyzed),GSM3713502,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0070,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580909,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358664,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654014,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0071 (re-analyzed),GSM3713503,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0071,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580910,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358663,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654015,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0075 (re-analyzed),GSM3713504,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0075,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580911,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358662,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654016,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0076 (re-analyzed),GSM3713505,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0076,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580912,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358661,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654017,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0077 (re-analyzed),GSM3713506,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0077,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580913,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358660,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654018,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0081 (re-analyzed),GSM3713507,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0081,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580914,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358659,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654019,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0082 (re-analyzed),GSM3713508,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0082,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580915,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358658,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654020,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0083 (re-analyzed),GSM3713509,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0083,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580916,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358657,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654021,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
C_0087 (re-analyzed),GSM3713510,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,C_0087,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580917,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358656,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654022,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0001 (re-analyzed),GSM3713511,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0001,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580918,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358655,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654023,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0002 (re-analyzed),GSM3713512,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0002,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580919,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358654,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654024,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0003 (re-analyzed),GSM3713513,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0003,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580920,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358653,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654025,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0005 (re-analyzed),GSM3713514,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0005,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580921,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358649,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654026,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0006 (re-analyzed),GSM3713515,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0006,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580922,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358648,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654027,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0007 (re-analyzed),GSM3713516,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0007,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580923,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358647,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654028,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0008 (re-analyzed),GSM3713517,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0008,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580924,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358646,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654029,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0009 (re-analyzed),GSM3713518,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0009,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580925,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358680,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654030,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0010 (re-analyzed),GSM3713519,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0010,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580926,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358652,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654031,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0012 (re-analyzed),GSM3713520,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0012,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580927,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358651,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654032,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0013 (re-analyzed),GSM3713521,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0013,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580928,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358650,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654033,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0539 (re-analyzed),GSM3713522,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0539,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580929,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358679,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654034,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0657 (re-analyzed),GSM3713523,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0657,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580930,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358678,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654035,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0658 (re-analyzed),GSM3713524,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0658,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580931,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358677,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654036,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0681 (re-analyzed),GSM3713525,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0681,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580932,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358676,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654037,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0695 (re-analyzed),GSM3713526,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0695,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580933,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358715,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654038,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0700 (re-analyzed),GSM3713527,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0700,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580934,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358714,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654039,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0726 (re-analyzed),GSM3713528,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0726,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580935,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358713,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654040,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0740 (re-analyzed),GSM3713529,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0740,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580936,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358712,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654041,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
H_0750 (re-analyzed),GSM3713530,Public on Apr 09 2019,Apr 08 2019,Jan 12 2022,SRA,1,BA9 prefrontal cortex,Homo sapiens,disease state: Huntington's Disease,tissue: brain,tissue region: BA9 prefrontal cortex,polyA RNA,"QIAzol, Qiagen miRNeasy kit","Illumina TruSeq RNA Sample Prep Kit, mRNA",9606,all_norm.csv,H_0750,Bases were called with the Illumina CASAVA 1.7 pipeline,"mRNA-Seq reads were aligned against UCSC hg19 genome build with STAR 2.5.3, parameters --runThreadN 8 --runMode alignReads --readFilesCommand zcat --outSAMtype BAM Unsorted",Aligned reads were counted against the Gencode v25 annotation gtf using Salmon 0.8.2,Genes were filtered from further analysis that had more than half of both HD and Control samples with zero counts,Outlier sample counts in individual genes were filtered,Differential expression between HD and Control was assessed using DESeq2 v1.3.34,Genome_build: hg19,Supplementary_files_format_and_content: processed file contains normalized counts for all samples,GPL11154,"Adam,,Labadorf",labadorf@bu.edu,Neurology,Boston University Medical School,72 East Concord Street E301,Boston,MA,02118,USA,0,Illumina HiSeq 2000,cDNA,transcriptomic,RNA-Seq,Reanalysis of: GSM1580937,BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN11358711,SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX5654042,NONE,Huntington's Disease,BA9 prefrontal cortex,brain,HD
